ONYX PHARMACEUTICALS INC Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
ONYX PHARMACEUTICALS INC had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value of $22.95 million as of 2012-06-30, per its 10-Q filed 2012-08-06.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue · last filed 2012-08-06
- 2012-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $22.95M.
- 2012-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $22.38M.
- 2011-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $22.10M.
- 2011-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $22.84M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value |
|---|---|
| 2012-06-30 | $22.95M 10-Q · filed 2012-08-06 |
| 2012-03-31 | $22.38M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $22.10M 10-Q · filed 2012-08-06 |
| 2011-09-30 | $22.84M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $28.05M 10-Q · filed 2012-08-06 |
| 2011-03-31 | $28.29M 10-Q · filed 2012-05-04 |
| 2010-12-31 | $28.55M 10-Q · filed 2012-08-06 |
| 2010-09-30 | $31.55M 10-Q · filed 2011-11-03 |
| 2009-12-31 | $37.17M 10-K · filed 2012-02-27 |
| 2008-12-31 | $39.62M 10-K · filed 2012-02-27 |